Ryan Weispfenning | Vice President and Head, Investor Relations |
Geoff Martha | Chairman and Chief Executive Officer |
Karen Parkhill | Chief Financial Officer |
Sean Salmon | Executive Vice President and President, Cardiovascular and Diabetes |
Bob White | Executive Vice President and President, Medical Surgical |
Brett Wall | Executive Vice President and President, Neuroscience |
Robbie Marcus | JPMorgan |
Vijay Kumar | Evercore ISI |
Pito Chickering | Deutsche Bank |
Matt Miksic | Credit Suisse |
Larry Biegelsen | Wells Fargo |
Danielle Antalffy | SVB Leerink |
Rick Wise | Stifel |
Good morning and welcome to a balmy February morning here in Minnesota. I am Ryan Weispfenning, Vice President and Head of Medtronic Investor Relations, and I am pleased that you are joining us for Medtronic’s Fiscal Year 2022 Third Quarter Earnings Video Webcast.
Before we start the prepared remarks, I will share a few details about today’s webcast.
Joining me are Geoff Martha, Medtronic Chairman and Chief Executive Officer and Karen Parkhill, Medtronic Chief Financial Officer. Geoff and Karen will provide comments on the results of our third quarter, which ended on January 28, 2022 and our outlook for the remainder of the fiscal year.